Appl Health Econ Health Policy (2018) 16:537–548 https://doi.org/10.1007/s40258-018-0397-3 OR IGINAL RESEARCH ARTIC L E Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert MTB/RIF for People Living with HIV/ AIDS and People with Presumptive Multidrug-resistant Tuberculosis 1 1 2 2 • • • • Sarah Wood Pallas Marissa Courey Chhaily Hy Wm. Perry Killam 2 3 Dora Warren Brittany Moore Published online: 4 June 2018 This is a U.S. government work and its text is not subject to copyright protection in the United States; however, its text may be subject to foreign copyright protection 2018 Abstract collected at four sites through observation, records review, Background The Xpert MTB/RIF (Xpert) test has been and key informant consultations. shown to be effective and cost-effective for diagnosing Results Across the sample facilities, the cost per Xpert test tuberculosis (TB) under conditions with high HIV preva- was US$33.88–US$37.11, clinical exam cost US$1.22– lence and HIV-TB co-infection but less is known about US$1.84, chest X-ray cost US$2.02–US$2.14, ﬂuorescent Xpert’s cost in low HIV prevalence settings. Cambodia, a microscopy (FM) smear cost US$1.56–US$1.93, Ziehl– country with low HIV prevalence (0.7%), high TB burden, Neelsen (ZN) smear cost US$1.26, liquid culture test cost and
Applied Health Economics and Health Policy – Springer Journals
Published: Jun 4, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera